At-Home Oasis
In these plush pools, you can go splish, splash and your stress will fade in a flash
Shailaja Mohapatra - May 25, 2020
Kiran Mazumdar Shaw’s multi-billion dollar baby
Biocon Biologics’ valuation has raised eyebrows. But the parent has strong growth on its side and a track record of solid execution
Kripa Mahalingam - April 25, 2020
How Biocon has been leading from the front | Editor's Note
Kiran Mazumdar Shaw's bold biologics bet is set to reap rewards
N Mahalakshmi - April 25, 2020
How India Inc is countering coronavirus | Editor's note
Top India Inc honchos share their insights on what needs to be done
N Mahalakshmi - April 16, 2020
Biocon's Kiran Mazumdar Shaw's prescription for fighting COVID-19
Biocon CMD shares her insights on how Indian biotech industry can leverage the coronavirus crisis and turn it into a massive opportunity
Hari Menon - April 11, 2020
Looks good, but <br> far from scrumptious </br>
Demergers and spin-offs have not always worked wonders
Jitendra Kumar Gupta - September 03, 2015
No trial, no error
What’s worrying Kiran Mazumdar Shaw and other pharma players
N Mahalakshmi - June 17, 2015
A Mighty heart
Nothing less than healthcare for all will satisfy this cardiologist
Kripa Mahalingam - June 24, 2015
"Keep questioning the business model all the time"
Biocon founder Kiran Mazumdar-Shaw traces her journey from brewmaster to biotech pioneer
Kripa Mahalingam - December 23, 2015
